PortfoliosLab logo

Acumen Pharmaceuticals, Inc. (ABOS)

Equity · Currency in USD · Last updated Feb 4, 2023

Company Info

ISINUS00509G2093
CUSIP00509G209
SectorHealthcare
IndustryBiotechnology

Trading Data

Previous Close$5.75
Year Range$3.08 - $10.48
EMA (50)$5.88
EMA (200)$5.64
Average Volume$95.85K
Market Capitalization$235.32M

ABOSShare Price Chart


Loading data...

ABOSPerformance

The chart shows the growth of $10,000 invested in Acumen Pharmaceuticals, Inc. in Sep 2022 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $2,861 for a total return of roughly -71.39%. All prices are adjusted for splits and dividends.


-20.00%0.00%20.00%40.00%60.00%80.00%OctoberNovemberDecember2023February
-5.58%
4.27%
ABOS (Acumen Pharmaceuticals, Inc.)
Benchmark (^GSPC)

ABOSCompare to other instruments

Search for stocks, ETFs, and funds to compare with ABOS

Acumen Pharmaceuticals, Inc.

ABOSReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M9.32%8.17%
YTD6.48%7.73%
6M13.86%-0.37%
1Y15.46%-9.87%
5Y-54.46%-2.69%
10Y-54.46%-2.69%

ABOSMonthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
202321.67%
20224.60%76.27%-31.01%-17.92%-4.93%

ABOSSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Acumen Pharmaceuticals, Inc. Sharpe ratio is 0.12. A Sharpe ratio between 0 and 1.0 is considered sub-optimal.

The chart below displays rolling 12-month Sharpe Ratio.


-1.00-0.80-0.60-0.40-0.200.000.20OctoberNovemberDecember2023February
0.12
-0.41
ABOS (Acumen Pharmaceuticals, Inc.)
Benchmark (^GSPC)

ABOSDividend History


Acumen Pharmaceuticals, Inc. doesn't pay dividends

ABOSDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-80.00%-70.00%-60.00%-50.00%-40.00%-30.00%-20.00%-10.00%OctoberNovemberDecember2023February
-71.65%
-13.76%
ABOS (Acumen Pharmaceuticals, Inc.)
Benchmark (^GSPC)

ABOSWorst Drawdowns

The table below shows the maximum drawdowns of the Acumen Pharmaceuticals, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Acumen Pharmaceuticals, Inc. is 84.81%, recorded on May 11, 2022. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-84.81%Jul 6, 2021216May 11, 2022

ABOSVolatility Chart

Current Acumen Pharmaceuticals, Inc. volatility is 139.93%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


0.00%100.00%200.00%300.00%400.00%OctoberNovemberDecember2023February
139.93%
16.33%
ABOS (Acumen Pharmaceuticals, Inc.)
Benchmark (^GSPC)